Biotechnology has revolutionized the way cancer is diagnosed. Traditional methods like biopsies and imaging are now complemented by advanced techniques such as liquid biopsies, which detect circulating tumor DNA (ctDNA) in the blood. This allows for earlier and less invasive detection of cancers. Additionally, molecular diagnostics can identify specific genetic mutations that drive cancer, enabling personalized treatment plans.
